Maosheng Cheng
Shenyang Pharmaceutical University(CN)Zhejiang Chinese Medical University(CN)Shenyang Agricultural University(CN)Sun Yat-sen University(CN)Hebei University of Technology(CN)Wenzhou Medical University(CN)Soochow University(CN)Wenzhou Hospital of Traditional Chinese Medicine(CN)The First Affiliated Hospital, Sun Yat-sen University(CN)Bristol-Myers Squibb (Belgium)(BE)Drug Discovery Laboratory (Norway)(NO)First Affiliated Hospital of Soochow University(CN)
Publications by Year
Research Areas
Catalytic Alkyne Reactions, Computational Drug Discovery Methods, Natural product bioactivities and synthesis, Catalytic C–H Functionalization Methods, Chemical Synthesis and Analysis
Most-Cited Works
- → Trisulfide bond–mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity(2020)285 cited
- → Curcumin suppresses proliferation and invasion in human gastric cancer cells by down-regulation of PAK1 activity and cyclin D1 expression(2009)128 cited
- → Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells(2014)126 cited
- → Synthetic Approaches to Tetracyclic Indolines as Versatile Building Blocks of Diverse Indole Alkaloids(2018)102 cited
- → LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells(2011)100 cited
- → Hybrid chalcogen bonds in prodrug nanoassemblies provides dual redox-responsivity in the tumor microenvironment(2022)